The role of regional intra-arterial chemotherapy in the combined treatment of locally advanced laryngeal cancer

Mashkova T.A.

Kafedra otorinolaringologii Voronezhskoĭ gosudarstvennoĭ meditsinskoĭ akademii im. N.N. Burdenko MZ RF

Ol'shanskiĭ M.S.

Voronezhskaia oblastnaia klinicheskaia bol'nitsa #1

Panchenko I.G.

Voronezhskaia oblastnaia klinicheskaia bol'nitsa #1

Ovsiannikov Iu.M.

Voronezhskaia oblastnaia klinicheskaia bol'nitsa #1

Mal'tsev A.B.

Kafedra otorinolaringologii Voronezhskoĭ gosudarstvennoĭ meditsinskoĭ akademii im. N.N. Burdenko

The role of regional intra-arterial chemotherapy in the combined treatment of locally advanced laryngeal cancer

Authors:

Mashkova T.A., Ol'shanskiĭ M.S., Panchenko I.G., Ovsiannikov Iu.M., Mal'tsev A.B.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2013;78(5): 48‑50

Downloaded: 48

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Mashkova TA, Ol'shanskiĭ MS, Panchenko IG, Ovsiannikov IuM, Mal'tsev AB. The role of regional intra-arterial chemotherapy in the combined treatment of locally advanced laryngeal cancer. Russian Bulletin of Otorhinolaryngology. 2013;78(5):48‑50. (In Russ.)

Подписка 2025 (Russian Bulletin of Otorhinolaryngology)

Close metadata

Recommended articles:

Toxicity analysis during neoadjuvant induction chemotherapy and subsequent chemoradiotherapy in patients with locally advanced gastric cancer. P.A. Herzen Journal of Oncology. 2024;(2):15-20

The objective of the present study was to estimate the possibilities and prospects for the use of regional intra-arterial chemotherapy in the combined treatment of locally advanced laryngeal cancer. The results of the chemoradiotherapeutic treatment of 26 patients presenting with locally advanced laryngeal cancer were analysed. The chemical agents were selectively administered intra-arterially three times from the right-hand femoral access by the standard procedure at a total focal dose (TFD) of 26 and 50 gram prior to the onset of and during of radiotherapy. The very first administration of the chemical agent resulted in the 30% decrease the tumour size. It further decreased by 70% on the average after the TFD of 50 gram was achieved. It made possible the continuation of gamma-therapy up to the total therapeutic dose. As a result, complete regression of the tumour was documented. The dynamic endoscopic control study and CT of the larynx revealed recurrent laryngeal cancer in 1 of the 26 patients (3.8%). The remaining patients did not develop metastases during the 18 month follow-up period. It is concluded that the results of the present study confirm high (96.2%) effectiveness of the method employed in this study which allows it to be recommended for the organ-preserving treatment of locally advanced laryngeal cancer

Keywords:

locally advanced laryngeal cancer

chemoradiotherapy

organ-preserving techniques

Authors:

Mashkova T.A.

Kafedra otorinolaringologii Voronezhskoĭ gosudarstvennoĭ meditsinskoĭ akademii im. N.N. Burdenko MZ RF

Ol'shanskiĭ M.S.

Voronezhskaia oblastnaia klinicheskaia bol'nitsa #1

Panchenko I.G.

Voronezhskaia oblastnaia klinicheskaia bol'nitsa #1

Ovsiannikov Iu.M.

Voronezhskaia oblastnaia klinicheskaia bol'nitsa #1

Mal'tsev A.B.

Kafedra otorinolaringologii Voronezhskoĭ gosudarstvennoĭ meditsinskoĭ akademii im. N.N. Burdenko

List of references:

Paches A.I., Ol'shanskii V.O., Lyubaev V.L., Tuok T.Kh. V kn.: Zlokachestvennye opukholi polosti rta, glotki i gortani. M: Meditsina 1988; 162-232.
Ogol'tsova E.S., Dvoirin V.V., Alferov V.S. Statistika i dogospital'naya diagnostika zlokachestvennykh novoobrazovanii verkhnikh dykhatel'nykh putei v Rossii. Vestn otorinolar 1994; 1: 5-9.
Osipov V.D., Mingalev N.V., Shelkovnikov A.V., Makhov V.A. K problemam raka gortani. Materialy Yubileinoi nauch.-prakt. konf., posvyashchennoi 75-letiyu gorodskoi klinicheskoi bol'nitsy №1 Novokuznetska (28-30 sentyabrya 2004 g.): Sbornik nauch. tr. Kemerovo 2004; 1: 413-416.
Narozny W. Begin neoplasms of the larynx. Auris Nasus Larynx 1995; 22: 33-42.
Hart A.A., Mak-Kregar S., Hilgers F.J., Levendag P.C., Manni J.J., Spoelstra H.A., Bruaset I.A., van der Laan B.F., Annyas A.A., van der Beek J.M. The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in The Netherlands. Cancer 1995; 75: 2656-2662.
Dar'yalova S.L. Khimicheskaya radiosensibilizatsiya zlokachestvennykh opukholei. Materialy V Rossiiskoi onkologicheskoi konferentsii. M 2001; 102-103.
Cox J.D., Pajak T.F., Marcial V.A. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13. Inter J Radiat Oncol Biol Phys 1990; 18: 3: 515-521.
Matakova I.S. Rezul'taty khimioluchevogo lecheniya raka gortani T3N0M0. Materialy VIII Rossiiskogo onkologicheskogo kongressa. M 2004; 136-139.
El-Sayed S., Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 1996; 14: 838-847.
Perevodchikova N.I. Khimioterapiya opukholevykh zabolevanii. Kratkoe rukovodstvo. M: Meditsina 2004.
Kovtunenko A.V. Khimioterapiya ploskokletochnogo raka gortani. Ukraїns'kii zhurnal ekstremal'noї meditsini іmenі G.O. Mozhaєva 2009; 10: 1: 100-110.
Hanna E., Alexiou M., Morgan J., Badley J., Maddox A.M., Penagaricano J., Fan C.Y., Breau R. Suen J. Intensive chemoradiotherapy as a primary treatment for organ preservaton in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg 2004; 130: 7: 861-867.
Shanturov A.G., Pogosov V.S., Potapov I.I. Shchadyashchaya khirurgiya v sochetanii s regionarnoi i sistemnoi khimioterapiei raka gortani. Irkutsk: Vostoch-Sib kn izd-vo 1977.
Samant S., Robbins K.T., Kumar P., Ma J.Z., Vieira F., Hanchett C. Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation. Arch Otolarynogol Head Neck Surg 2001; 127: 1451-1456.
Nashimura T., Sanada J., Furukawa M. Cervical radiculopathy due to inra-arterial unfusion of cisplatin. J Laryngol Otol 2005; 119: 8: 649-650.
Gasparyan S.A., Ostroverkhov G.E., Trapeznikov N.N. Regionarnaya dlitel'naya vnutriarterial'naya khimioterapiya zlokachestvennykh opukholei. M: Meditsina 1970.
Robbins K.T., Vicario D., Seagren S., Weisman R., Pellitteri P., Kerber C., Orloff L., Los G., Howell S.B. A target supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994; 168: 5: 419-422.
Robbins K.T., Fontanesi J., Wong F.S., Vicario D., Seagren S., Kumar P., Weisman R., Pellitteri P., Thomas J.R., Flick P., Palmer R., Weir A.B. 3rd, Kerber C., Murry T., Ferguson R., Los G., Orloff L., Howell S.B. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 1996; 122: 8: 853-857.
Nabiev A.K., Arybzhanov D.T. Vnutriarterial'naya khimioterapiya pri rake gortani. Sib onkol zhurn 2007; prilozhenie 2: 77-78.
Corry J., Peters L.J., Rischin D. Optimising the therapeutic ratio in head and neck cancer. Lancet Oncol 2010; 11: 3: 287-291.

Close metadata